Jean-Francois Billet
Senior Partner @ Mérieux Equity Partners
Lyon, France
Jean-Francois Billet is a funding round investor at Mérieux Equity Partners in Lyon focused on Health Care and Manufacturing. Jean-François holds a Phd in Pharmacy and graduated from ESSEC in Paris. He started his career with Pasteur-Mérieux (now Sanofi-Pasteur), the leading global vaccine manufacturer, as Southeast Asia Marketing Manager. Then Joining bioMérieux he developed the company’s initial strategy in Food Safety and Quality services, leading to the investment inSilliker (now Mérieux NutriSciences). Later, he managed Commercial and Business Development operations for bioMérieux Industry, a business Unit of bioMérieux. He then served as Principal at Mercer Management Consulting (now Oliver Wyman), a strategy and management consulting firm, doing extensive work in the fields of sales force effectiveness, operational optimization and growth strategy. Prior to joining Mérieux Developpement, he served as Senior Vice-President at Mérieux NutriSciences, in charge of Strategy, M&A activities and overseeing operations in various geographical zones.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jean-Francois Billet invests in
Stages Jean-Francois Billet invests in
Countries Jean-Francois Billet invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Manufacturing 1 (50%)
- Medical Device 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Stiplastics S.A.S.
|
Stiplastics S.A.S. engages in designing, developing, and manufacturing medical devices for the healthcare industry | Jan 18, 2018 | |
|
Stiplastics S.A.S.
|
Stiplastics S.A.S. engages in designing, developing, and manufacturing medical devices for the healthcare industry | Jan 18, 2018 |
Co-Investors
About Mérieux Equity Partners
Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.
Mérieux Equity Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Francois Valencony
Managing Partner,/founder & Executive Officer; Managing Partner & Executive Officer
|
|||
|
Jean-Francois Billet
Senior Partner
|
|||
Jean-Guillaume Lafay
Operating Partner
|
|||
Thierry Chignon
Senior Partner
|
|||
Valerie Calenda
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jean-Francois Billet invest in?
Jean-Francois Billet invests primarily in Health Care, Manufacturing and Medical Device startups, most often at Funding Round stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jean-Francois Billet last invest?
The most recent investment recorded for Jean-Francois Billet closed in Jan 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
